tradingkey.logo
tradingkey.logo
Suchen

Bio Rad Laboratories Inc

BIOb
Zur Watchlist hinzufügen
321.500USD
+25.010+8.44%
Handelsschluss 06/26, 16:00ETKurse um 15 Minuten verzögert
8.63BMarktkapitalisierung
53.32KGV TTM

mehr Informationen über Bio Rad Laboratories Inc Unternehmen

Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.

Bio Rad Laboratories Inc Informationen

BörsenkürzelBIOb
Name des UnternehmensBio Rad Laboratories Inc
IPO-datumMar 17, 1980
CEOSchwartz (Norman D)
Anzahl der mitarbeiter7700
WertpapierartOrdinary Share
GeschäftsjahresendeMar 17
Addresse1000 Alfred Nobel Dr
StadtHERCULES
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited States of America
Postleitzahl94547
Telefon15107247000
Websitehttps://www.bio-rad.com/
BörsenkürzelBIOb
IPO-datumMar 17, 1980
CEOSchwartz (Norman D)

Führungskräfte von Bio Rad Laboratories Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Norman D. Schwartz
Mr. Norman D. Schwartz
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
431.47K
+13.21%
Mr. Jeffrey L. (Jeff) Edwards
Mr. Jeffrey L. (Jeff) Edwards
Independent Director
Independent Director
--
--
Mr. Gregory K. (Greg) Hinckley, CPA
Mr. Gregory K. (Greg) Hinckley, CPA
Lead Independent Director
Lead Independent Director
--
--
Ms. Melinda Litherland
Ms. Melinda Litherland
Independent Director
Independent Director
--
--
Mr. Arnold A. Pinkston
Mr. Arnold A. Pinkston
Independent Director
Independent Director
--
--
Mr. Edward Chung
Mr. Edward Chung
Vice President - Investor Relations
Vice President - Investor Relations
--
--
Ms. Allison Schwartz
Ms. Allison Schwartz
Director
Director
--
--
Mr. Roop K. Lakkaraju
Mr. Roop K. Lakkaraju
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Ms. Colleen Corey
Ms. Colleen Corey
Executive Vice President, Global Human Resources
Executive Vice President, Global Human Resources
--
--
Mr. Sedat Evran
Mr. Sedat Evran
Executive Vice President - Global Supply Chain
Executive Vice President - Global Supply Chain
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Norman D. Schwartz
Mr. Norman D. Schwartz
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
431.47K
+13.21%
Mr. Jeffrey L. (Jeff) Edwards
Mr. Jeffrey L. (Jeff) Edwards
Independent Director
Independent Director
--
--
Mr. Gregory K. (Greg) Hinckley, CPA
Mr. Gregory K. (Greg) Hinckley, CPA
Lead Independent Director
Lead Independent Director
--
--
Ms. Melinda Litherland
Ms. Melinda Litherland
Independent Director
Independent Director
--
--
Mr. Arnold A. Pinkston
Mr. Arnold A. Pinkston
Independent Director
Independent Director
--
--
Mr. Edward Chung
Mr. Edward Chung
Vice President - Investor Relations
Vice President - Investor Relations
--
--

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Bio Rad Laboratories Inc?

Die fünf größten Anteilseigner von Bio Rad Laboratories Inc sind: Mr. Norman D. Schwartz

Wie viele Institutionen halten Anteile an Bio Rad Laboratories Inc (BIOb)?

Mit Stand vom 2026Q1 halten 13 Institutionen Anteile an Bio Rad Laboratories Inc, mit einem Gesamtmarktwert von etwa 3.75K, was 0.07% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -232.00 gestiegen.
KeyAI